AWS for Industries

Tag: pharma

GxPLogoAws

Whitepaper: Building a solid foundation for GxP-regulated workloads on AWS

For customers looking to implement a GxP-compliant environment on AWS, we have released a new whitepaper: GxP Systems on AWS. Access Whitepaper This whitepaper provides essential information and guidance on building GxP-regulated systems using AWS services, and outlines how AWS approaches GxP-related compliance and security. Building on our previous GxP guidance, the content of this […]

Read More

Executive Conversations: Modernizing the approach to healthcare data with Andrew Goldberg, Co-founder and COO of HealthVerity

Andrew Goldberg, Co-founder and COO of HealthVerity, joins Jared Saul, Global Head of Healthcare and Life Sciences Startups at AWS, for a discussion on industry trends shaping the way payors and pharmaceutical organizations exchange and manage data, the role of real-time data in COVD-19 vaccine development, and a vision for a flexible data strategy. HealthVerity, […]

Read More

Executive Conversations: Accelerating COVID-19 vaccine development with Marcello Damiani, Chief Digital and Operational Excellence Officer at Moderna

Marcello Damiani, Chief Digital and Operational Excellence Officer at Moderna, joins Todd Weatherby, Vice President of AWS Professional Services Worldwide, for a discussion on developing Moderna’s COVID-19 vaccine, scaling systems to enable global distribution, and leveraging cloud technologies to accelerate processes. Moderna is pioneering a new class of medicines made of messenger RNA, or mRNA, […]

Read More

[In the News] Bristol Myers Squibb’s Flawless Migration from SAP ECC to S/4HANA on AWS

This article originally appeared on Accenture. Challenge Digital technologies are transforming the life sciences industry as much as advanced science. The ability to extract, analyze and visualize data quickly from across the company can help biopharmaceutical companies become intelligent enterprises and better serve patients. Bristol Myers Squibb (BMS), a global leading biopharma company, is intent […]

Read More
scientist-samples

[In the News] Machine Learning is Transforming Drug Discovery at AstraZeneca

This article originally appeared on Wired. Disease understanding and drug discovery is based on scientific rigor. And while it’s work that is potentially life changing, it can also be tedious and time-consuming. Few know this better than Magnus Söderberg, a pathology researcher with more than 20 years of lab experience and the director and technical […]

Read More

Building a COVID-19 Vaccine Verification Solution on AWS

Buying a COVID-19 vaccination on the dark web for upwards of $1000 only for it never to materialize sounds like something from a Hollywood script. But according to cybersecurity agencies like Check Point, this situation is presenting itself to patients eager for vaccinations.  Fraudulent activities like this and fake drug products such as those described […]

Read More

Executive Conversations: Evolving R&D with Siping “Spin” Wang, President and CTO of TetraScience

Ground-breaking new therapies and scientific advances in technology are driving the exponential rate of innovation in the pharmaceutical industry. With the explosion of big data and the complexity that comes with it, leaders in life sciences research and development (R&D) are adopting digital transformation to speed up discovery and maximize investments. Siping “Spin” Wang, President […]

Read More

DRAGEN reanalysis of the 1000 Genomes Dataset now available on the Registry of Open Data

Guest authored by Bryan Lajoie, Staff Bioinformatics Scientist at Illumina Inc. — We are pleased to announce the release of a comprehensive reanalysis of 3,202 deeply-sequenced samples from the 1000 Genomes Project(1kGP) using the Illumina DRAGEN (Dynamic Read Analysis for GENomics) Bio-IT platform. This seminal dataset will be freely available for researchers across the world to use […]

Read More

Conducting end-to-end pharmacovigilance workflows using AWS technologies

Introduction Bio-pharmaceutical companies have always had a responsibility to report adverse events (AE), whether in clinical development or post market-approval scenarios, to the Food and Drug Administration (FDA).  The COVID-19 pandemic and the race to find effective treatments for this disease has caused both the FDA and bio-pharmaceutical organizations around the world to re-imagine the […]

Read More

Approving AWS services for GxP workloads

In this blog post, we describe the first step of a process for qualifying AWS services for use as part of GxP workloads, sometimes referred to in the industry as “whitelisting” services. AWS customers with GxP compliance requirements might want to control access to the AWS services their developers use. During the supplier assessment of […]

Read More